Identifikatu
Taldeak
Ikertzaileak
Finantzaketa
Emaitzak
Linfomas
GLUN
Mutua de Terrassa
Terrassa, España
Hemen zaude
Lankidetzak
Mutua de Terrassa
Mutua de Terrassa -ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2022
A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
Leukemia and Lymphoma, Vol. 63, Núm. 1, pp. 93-100
2009
Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type
Cancer, Vol. 115, Núm. 22, pp. 5210-5217
Kontaktua
Lege-oharra
Laguntza
translate
eu
arrow_drop_down
translate
eu
arrow_drop_down
es
ca
gl
en
fr
de